source
- Family reflects on extra months gained from new pancreatic cancer drug daraxonrasibBobby Senaha was among the first patients to receive daraxonrasib, a new medicine aimed at extending survival for people with pancreatic cancer. The drug is described as life extending, offering p…
- Lung cancer patient credits targeted therapy for 15-year survival, notes limited benefit for othersA lung cancer patient described how a targeted drug allowed her to live for 15 years after diagnosis. She highlighted that while her own quality of life improved, many of her peers who received th…